drug
apixaban ER
Preclinicalupdated 5mo agoby Taho Pharmaceuticals Ltd
Preclinicalcommunity read0 votes
🐶 often sniffed alongside
top 8- drugapixaban5 co-mentions · 2 sources
- drugapixaban ODT5 co-mentions · 2 sources
- tagOncology2 co-mentions · 1 sources
- tagHematology2 co-mentions · 1 sources
- tagAdCom2 co-mentions · 1 sources
- tag510(k) Clearance2 co-mentions · 1 sources
- tagDiagnostics Company2 co-mentions · 1 sources
- companyMedical University of Gdansk1 co-mentions · 1 sources
all catalysts(0)
nothing on the calendar yet
Trials studying apixaban ER
- phase3Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- phase1Single Dose Trial of VMX-C001 in Healthy Subjects With and Without FXa Direct Oral Anticoagulant
- N/ADEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
- phase2Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- phase3Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
- phase3A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
- phase1A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants
- phase3REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that